Author: improzo_admin
April 01, 2026
Rethinking AI Strategy in Commercial Analytics
Improzo Insights Perspectives from practitioners in commercial analytics and AI Executive…
Read More
March 13, 2026
From Decks to Engines: How Generative AI Is Reshaping Pharma…
Over the past decade, pharmaceutical organizations have invested heavily in modernizing…
Read More
March 02, 2026
From Agentic AI to Agentic Decision Infrastructure
Why AI-Native Execution Infrastructure Is Becoming the Differentiator in Life Sciences…
Read More
February 27, 2026
Smarter Market Access and Launch Execution in the Age of…
This perspective reflects observations from working with market access, medical, and…
Read More
February 23, 2026
Execution-Native AI for Qualitative Market Research
Making Human Insight Reusable Without Replacing Human Judgment Executive Summary Qualitative…
Read More
February 10, 2026
What If Every Patient Had an AI Advocate?
A Commercial Life Sciences View on Intelligent Engagement “Voice will become…
Read More
January 13, 2026
CRM Modernization in Life Sciences: Turning Insight into Execution
Why Rare Disease Exposes CRM Weaknesses Faster Life sciences organizations have…
Read More
January 13, 2026
Agentic AI in Pharma Commercial & Medical: A Practical FAQ…
Why We Created This FAQ Over the past year, we’ve had…
Read More
September 20, 2025
Q&A: Redefining Market Intelligence in Life Sciences— From Static Reports…
A conversation with Jane Urban, Chief Data & Analytics Officer at…
Read More
September 09, 2025
Rethinking CRM in Life Sciences: The Shift From Call Logging…
For decades, CRM in life sciences was treated as a compliance…
Read More